Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2024-08-21

Original market date: See footnote 1

1999-04-01

Product name:

TRINIPATCH 0.2

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02230732

Product Monograph/Veterinary Labelling:

Date: 2024-08-21 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

ENDO OPERATIONS LTD.
1st Floor, Minerva House, Simmonscourt Road
Ballsbridge
Dublin
Ireland D04 H9P8

Class:

Human

Dosage form(s):

Patch

Route(s) of administration:

Transdermal

Number of active ingredient(s):

1

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

24:12.08 

Anatomical Therapeutic Chemical (ATC): See footnote 4

C01DA02 GLYCERYL TRINITRATE

Active ingredient group (AIG) number:See footnote5

0103615026

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
NITROGLYCERIN 0.2 MG / HOUR
Version 4.0.3

"Page details"

Date modified: